Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis
- 1 November 2016
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 311 (5) , G807-G816
Abstract
Epidermal growth factor receptor (EGFR) and its ligands have been implicated in liver fibrosis. However, it has not been directly shown that hepatocellular genetic ablation of either this receptor tyrosine kinase or ERBB3, its interactive signaling partner, affects hepatic fibrosis. Carbon tetrachloride (CCl4)-induced liver fibrosis in hepatocyte-specific (HS) mouse models of EGFR and ERBB3 ablation was evaluated in both single gene knockouts and an HS-EGFR-ERBB3 double knockout (DKO). Loss of hepatocellular EGFR or ERBB3 did not impact cytochrome P450-2E1 expression, the extent of centrilobular injury, or the initial regenerative response, but it did diminish liver fibrosis induced by chronic intraperitoneal administration of CCl4. The reduction of liver fibrosis correlated with reduced α-smooth muscle actin expression. Maximal impact to fibrogenesis occurred in the ERBB3 and EGFR-ERBB3 DKO models, suggesting that EGFR-ERBB3 heterodimeric signaling in damaged hepatocytes may play a more important role in liver fibrosis than EGFR-EGFR homodimeric signaling. Immunohistochemical analyses of phospho-EGFR and phospho-ERBB3 isoforms revealed clear staining in hepatocytes, activated stellate cells, and macrophages. Our results support a role for the hepatocellular ERBB tyrosine kinases in fibrogenesis and suggest that pharmacologic inhibition of EGFR-ERBB3 signaling may reverse or retard hepatic fibrosis.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (RO1DK53804)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAA) (R21 AA021443)
- NCI (RO1CA092479)
This publication has 49 references indexed in Scilit:
- Loss of c-Met accelerates development of liver fibrosis in response to CCl4 exposure through deregulation of multiple molecular pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in miceLaboratory Investigation, 2012
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein–mediated activationHepatology, 2010
- Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorBMC Gastroenterology, 2010
- Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epitheliumJournal of Clinical Investigation, 2009
- Epidermal growth factor receptor regulates pancreatic fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptorGenesis, 2008
- The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis†Hepatology, 2008
- Expression of Heparin-Binding EGF-like Growth Factor in Rat Liver Injured by Carbon Tetrachloride ord-GalactosamineBiochemical and Biophysical Research Communications, 1996
- Changes in Distribution and Activity of Glutamine Synthetase in Carbon Tetrachloride–Induced Cirrhosis in the Rat: Potential Role in HyperammonemiaHepatology, 1994